Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
75.5M
Number of holders
45
Total 13F shares, excl. options
20.5M
Shares change
+830K
Total reported value, excl. options
$201M
Value change
+$8.95M
Number of buys
21
Number of sells
-27
Price
$9.83

Significant Holders of Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) as of Q2 2021

61 filings reported holding GRTX - Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share as of Q2 2021.
Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 20.5M shares of 75.5M outstanding shares and own 27.16% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (4.36M shares), Sofinnova Investments, Inc. (3.08M shares), Novo Holdings A/S (2.46M shares), AIGH Capital Management LLC (2.02M shares), Blackstone Inc (1.68M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.51M shares), Tekla Capital Management LLC (1.04M shares), Nan Fung Group Holdings Ltd (613K shares), Rock Springs Capital Management LP (568K shares), and VANGUARD GROUP INC (482K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.